Global Ranibizumab Market Size, Status and Forecast 2024-2031

Report ID: 917491 | Published Date: Sep 2024 | No. of Page: 88 | Base Year: 2023 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Ranibizumab Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Single-use prefilled syringe
        1.2.3 Single-use glass vial
    1.3 Market by Application
        1.3.1 Global Ranibizumab Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 wAMD
        1.3.3 Diabetic Retinopathy (DR)
        1.3.4 Diabetic Macular Edema (DME)
        1.3.5 mCNV
        1.3.6 RVO
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Ranibizumab Market Perspective (2016-2027)
    2.2 Ranibizumab Growth Trends by Regions
        2.2.1 Ranibizumab Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Ranibizumab Historic Market Share by Regions (2016-2021)
        2.2.3 Ranibizumab Forecasted Market Size by Regions (2022-2027)
    2.3 Ranibizumab Industry Dynamic
        2.3.1 Ranibizumab Market Trends
        2.3.2 Ranibizumab Market Drivers
        2.3.3 Ranibizumab Market Challenges
        2.3.4 Ranibizumab Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Ranibizumab Players by Revenue
        3.1.1 Global Top Ranibizumab Players by Revenue (2016-2021)
        3.1.2 Global Ranibizumab Revenue Market Share by Players (2016-2021)
    3.2 Global Ranibizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Ranibizumab Revenue
    3.4 Global Ranibizumab Market Concentration Ratio
        3.4.1 Global Ranibizumab Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Ranibizumab Revenue in 2020
    3.5 Ranibizumab Key Players Head office and Area Served
    3.6 Key Players Ranibizumab Product Solution and Service
    3.7 Date of Enter into Ranibizumab Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Ranibizumab Breakdown Data by Type
    4.1 Global Ranibizumab Historic Market Size by Type (2016-2021)
    4.2 Global Ranibizumab Forecasted Market Size by Type (2022-2027)

5 Ranibizumab Breakdown Data by Application
    5.1 Global Ranibizumab Historic Market Size by Application (2016-2021)
    5.2 Global Ranibizumab Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Ranibizumab Market Size (2016-2027)
    6.2 North America Ranibizumab Market Size by Type
        6.2.1 North America Ranibizumab Market Size by Type (2016-2021)
        6.2.2 North America Ranibizumab Market Size by Type (2022-2027)
        6.2.3 North America Ranibizumab Market Size by Type (2016-2027)
    6.3 North America Ranibizumab Market Size by Application
        6.3.1 North America Ranibizumab Market Size by Application (2016-2021)
        6.3.2 North America Ranibizumab Market Size by Application (2022-2027)
        6.3.3 North America Ranibizumab Market Size by Application (2016-2027)
    6.4 North America Ranibizumab Market Size by Country
        6.4.1 North America Ranibizumab Market Size by Country (2016-2021)
        6.4.2 North America Ranibizumab Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Ranibizumab Market Size (2016-2027)
    7.2 Europe Ranibizumab Market Size by Type
        7.2.1 Europe Ranibizumab Market Size by Type (2016-2021)
        7.2.2 Europe Ranibizumab Market Size by Type (2022-2027)
        7.2.3 Europe Ranibizumab Market Size by Type (2016-2027)
    7.3 Europe Ranibizumab Market Size by Application
        7.3.1 Europe Ranibizumab Market Size by Application (2016-2021)
        7.3.2 Europe Ranibizumab Market Size by Application (2022-2027)
        7.3.3 Europe Ranibizumab Market Size by Application (2016-2027)
    7.4 Europe Ranibizumab Market Size by Country
        7.4.1 Europe Ranibizumab Market Size by Country (2016-2021)
        7.4.2 Europe Ranibizumab Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Ranibizumab Market Size (2016-2027)
    8.2 Asia-Pacific Ranibizumab Market Size by Type
        8.2.1 Asia-Pacific Ranibizumab Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Ranibizumab Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Ranibizumab Market Size by Type (2016-2027)
    8.3 Asia-Pacific Ranibizumab Market Size by Application
        8.3.1 Asia-Pacific Ranibizumab Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Ranibizumab Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Ranibizumab Market Size by Application (2016-2027)
    8.4 Asia-Pacific Ranibizumab Market Size by Region
        8.4.1 Asia-Pacific Ranibizumab Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Ranibizumab Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Ranibizumab Market Size (2016-2027)
    9.2 Latin America Ranibizumab Market Size by Type
        9.2.1 Latin America Ranibizumab Market Size by Type (2016-2021)
        9.2.2 Latin America Ranibizumab Market Size by Type (2022-2027)
        9.2.3 Latin America Ranibizumab Market Size by Type (2016-2027)
    9.3 Latin America Ranibizumab Market Size by Application
        9.3.1 Latin America Ranibizumab Market Size by Application (2016-2021)
        9.3.2 Latin America Ranibizumab Market Size by Application (2022-2027)
        9.3.3 Latin America Ranibizumab Market Size by Application (2016-2027)
    9.4 Latin America Ranibizumab Market Size by Country
        9.4.1 Latin America Ranibizumab Market Size by Country (2016-2021)
        9.4.2 Latin America Ranibizumab Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Ranibizumab Market Size (2016-2027)
    10.2 Middle East & Africa Ranibizumab Market Size by Type
        10.2.1 Middle East & Africa Ranibizumab Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Ranibizumab Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Ranibizumab Market Size by Type (2016-2027)
    10.3 Middle East & Africa Ranibizumab Market Size by Application
        10.3.1 Middle East & Africa Ranibizumab Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Ranibizumab Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Ranibizumab Market Size by Application (2016-2027)
    10.4 Middle East & Africa Ranibizumab Market Size by Country
        10.4.1 Middle East & Africa Ranibizumab Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Ranibizumab Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Genentech
        11.1.1 Genentech Company Details
        11.1.2 Genentech Business Overview
        11.1.3 Genentech Ranibizumab Introduction
        11.1.4 Genentech Revenue in Ranibizumab Business (2016-2021)
        11.1.5 Genentech Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Ranibizumab Introduction
        11.2.4 Novartis Revenue in Ranibizumab Business (2016-2021)
        11.2.5 Novartis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Ranibizumab Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Single-use prefilled syringe
    Table 3. Key Players of Single-use glass vial
    Table 4. Global Ranibizumab Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Ranibizumab Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Ranibizumab Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Ranibizumab Market Share by Regions (2016-2021)
    Table 8. Global Ranibizumab Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Ranibizumab Market Share by Regions (2022-2027)
    Table 10. Ranibizumab Market Trends
    Table 11. Ranibizumab Market Drivers
    Table 12. Ranibizumab Market Challenges
    Table 13. Ranibizumab Market Restraints
    Table 14. Global Ranibizumab Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Ranibizumab Market Share by Players (2016-2021)
    Table 16. Global Top Ranibizumab Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ranibizumab as of 2020)
    Table 17. Ranking of Global Top Ranibizumab Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Ranibizumab Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Ranibizumab Product Solution and Service
    Table 21. Date of Enter into Ranibizumab Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Ranibizumab Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Ranibizumab Revenue Market Share by Type (2016-2021)
    Table 25. Global Ranibizumab Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Ranibizumab Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Ranibizumab Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Ranibizumab Revenue Market Share by Application (2016-2021)
    Table 29. Global Ranibizumab Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Ranibizumab Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Ranibizumab Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Ranibizumab Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Ranibizumab Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Ranibizumab Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Ranibizumab Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Ranibizumab Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Ranibizumab Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Ranibizumab Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Ranibizumab Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Ranibizumab Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Ranibizumab Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Ranibizumab Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Ranibizumab Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Ranibizumab Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Ranibizumab Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Ranibizumab Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Ranibizumab Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Ranibizumab Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Ranibizumab Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Ranibizumab Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Ranibizumab Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Ranibizumab Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Ranibizumab Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Ranibizumab Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Ranibizumab Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Ranibizumab Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Ranibizumab Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Ranibizumab Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Ranibizumab Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Ranibizumab Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Genentech Company Details
    Table 62. Genentech Business Overview
    Table 63. Genentech Ranibizumab Product
    Table 64. Genentech Revenue in Ranibizumab Business (2016-2021) & (US$ Million)
    Table 65. Genentech Recent Development
    Table 66. Novartis Company Details
    Table 67. Novartis Business Overview
    Table 68. Novartis Ranibizumab Product
    Table 69. Novartis Revenue in Ranibizumab Business (2016-2021) & (US$ Million)
    Table 70. Novartis Recent Development
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Ranibizumab Market Share by Type: 2020 VS 2027
    Figure 2. Single-use prefilled syringe Features
    Figure 3. Single-use glass vial Features
    Figure 4. Global Ranibizumab Market Share by Application: 2020 VS 2027
    Figure 5. wAMD Case Studies
    Figure 6. Diabetic Retinopathy (DR) Case Studies
    Figure 7. Diabetic Macular Edema (DME) Case Studies
    Figure 8. mCNV Case Studies
    Figure 9. RVO Case Studies
    Figure 10. Ranibizumab Report Years Considered
    Figure 11. Global Ranibizumab Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Ranibizumab Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Ranibizumab Market Share by Regions: 2020 VS 2027
    Figure 14. Global Ranibizumab Market Share by Regions (2022-2027)
    Figure 15. Global Ranibizumab Market Share by Players in 2020
    Figure 16. Global Top Ranibizumab Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ranibizumab as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Ranibizumab Revenue in 2020
    Figure 18. Global Ranibizumab Revenue Market Share by Type (2016-2021)
    Figure 19. Global Ranibizumab Revenue Market Share by Type (2022-2027)
    Figure 20. North America Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Ranibizumab Market Share by Type (2016-2027)
    Figure 22. North America Ranibizumab Market Share by Application (2016-2027)
    Figure 23. North America Ranibizumab Market Share by Country (2016-2027)
    Figure 24. United States Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Ranibizumab Market Share by Type (2016-2027)
    Figure 28. Europe Ranibizumab Market Share by Application (2016-2027)
    Figure 29. Europe Ranibizumab Market Share by Country (2016-2027)
    Figure 30. Germany Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Ranibizumab Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Ranibizumab Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Ranibizumab Market Share by Region (2016-2027)
    Figure 40. China Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Ranibizumab Market Share by Type (2016-2027)
    Figure 48. Latin America Ranibizumab Market Share by Application (2016-2027)
    Figure 49. Latin America Ranibizumab Market Share by Country (2016-2027)
    Figure 50. Mexico Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Ranibizumab Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Ranibizumab Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Ranibizumab Market Share by Country (2016-2027)
    Figure 56. Turkey Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Genentech Revenue Growth Rate in Ranibizumab Business (2016-2021)
    Figure 60. Novartis Revenue Growth Rate in Ranibizumab Business (2016-2021)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Genentech
Novartis
Frequently Asked Questions
Ranibizumab report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ranibizumab report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ranibizumab report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Varenicline

Varenicline (trade name Chantix and Champix), is a prescription medication used to treat nicotine ... Read More

Arformoterol

Arformoterol is a long-acting β2 adrenoreceptor agonist (LABA) indicated for the treatment of ch ... Read More

Ambrisentan Drug

Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MS ... Read More

Aliskiren

Aliskiren (trade names Tekturna and Rasilez) is the first in a class of drugs called direct renin ... Read More